We report RNA sequencing data from enriched prostate circulating tumor cells (CTCs) from clinical blood specimens. The goal is to examine the stability of RNA signatures as a function of whole blood preservation. Each blood sample was split into two equal portions; one portion was processed immediately (i.e., 0 hour) for CTC isolation; the other was preserved in 4 deg C, using methods described in this publication, for 24, 48, or 72 hours prior to CTC isolation. CTCs were isolated using the CTC-iChip and processed for RNA sequencing. SOURCE: David,T,Ting (dtting1@partners.org) - Ting Lab Massachusetts General Hospital

Pluto Bioinformatics

GSE104209: Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells